RJ, B., E, N. T., L, R., I, H., & DM, K. (2023). Meta-Analysis on Drug and Device Therapy of New York Heart Association Functional Class IV Heart Failure With Reduced Ejection Fraction. The American journal of cardiology, 188, 52. https://doi.org/10.1016/j.amjcard.2022.11.001
Chicago Style (17th ed.) CitationRJ, Batchelor, Nan Tie E, Romero L, Hopper I, and Kaye DM. "Meta-Analysis on Drug and Device Therapy of New York Heart Association Functional Class IV Heart Failure With Reduced Ejection Fraction." The American Journal of Cardiology 188 (2023): 52. https://doi.org/10.1016/j.amjcard.2022.11.001.
MLA (9th ed.) CitationRJ, Batchelor, et al. "Meta-Analysis on Drug and Device Therapy of New York Heart Association Functional Class IV Heart Failure With Reduced Ejection Fraction." The American Journal of Cardiology, vol. 188, 2023, p. 52, https://doi.org/10.1016/j.amjcard.2022.11.001.